Allied Biotech Corporation (TPEX:1780)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.80
-0.25 (-0.81%)
Apr 29, 2026, 1:07 PM CST

Allied Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
789.08978.33618.49679.75757.39
Upgrade
Short-Term Investments
64.838.91106.28113.25386.82
Upgrade
Cash & Short-Term Investments
853.91987.24724.777931,144
Upgrade
Cash Growth
-13.51%36.21%-8.60%-30.69%19.27%
Upgrade
Accounts Receivable
137.95131.24109.85118.54105.08
Upgrade
Other Receivables
1.531.753.65.394.63
Upgrade
Receivables
139.48132.99113.46123.92109.71
Upgrade
Inventory
511.41527.54601.48596.47508.09
Upgrade
Other Current Assets
16.6815.3317.1721.5423.52
Upgrade
Total Current Assets
1,5211,6631,4571,5351,786
Upgrade
Property, Plant & Equipment
540.7567.87594623.49625.99
Upgrade
Long-Term Investments
--0.050.732.59
Upgrade
Long-Term Deferred Tax Assets
21.5716.6717.3712.5515.44
Upgrade
Other Long-Term Assets
8.059.2210.6211.3111.84
Upgrade
Total Assets
2,0922,2572,0792,1832,441
Upgrade
Accounts Payable
31.126.6627.6538.6447.21
Upgrade
Accrued Expenses
49.847.9435.543.7830.61
Upgrade
Short-Term Debt
6708707007201,110
Upgrade
Current Portion of Long-Term Debt
18.3118.3118.3118.31125.99
Upgrade
Current Portion of Leases
5.055.365.15.495.79
Upgrade
Current Income Taxes Payable
15.1210.8816.8527.461.64
Upgrade
Current Unearned Revenue
1.692.64.641.261.59
Upgrade
Other Current Liabilities
8.9814.520.6539.8423.91
Upgrade
Total Current Liabilities
800.04996.25828.69894.771,347
Upgrade
Long-Term Debt
34.4652.7671.0789.38-
Upgrade
Long-Term Leases
4.17.740.953.891.03
Upgrade
Pension & Post-Retirement Benefits
8.95-5.923.949.64
Upgrade
Long-Term Deferred Tax Liabilities
9.644.573.497.432.47
Upgrade
Total Liabilities
857.191,061910.12999.41,360
Upgrade
Common Stock
962.43960.24957.85953.85953.51
Upgrade
Additional Paid-In Capital
12.139.657.745.675.19
Upgrade
Retained Earnings
263.95231.31209.28229.88127.6
Upgrade
Comprehensive Income & Other
-3.9-5.67-6.08-5.79-4.79
Upgrade
Shareholders' Equity
1,2351,1961,1691,1841,082
Upgrade
Total Liabilities & Equity
2,0922,2572,0792,1832,441
Upgrade
Total Debt
731.91954.17795.43837.071,243
Upgrade
Net Cash (Debt)
12233.07-70.66-44.06-98.6
Upgrade
Net Cash Growth
268.93%----
Upgrade
Net Cash Per Share
1.270.34-0.74-0.46-1.03
Upgrade
Filing Date Shares Outstanding
96.2496.0295.7895.3895.35
Upgrade
Total Common Shares Outstanding
96.2496.0295.7895.3895.35
Upgrade
Working Capital
721.44666.85628.19640.17438.79
Upgrade
Book Value Per Share
12.8312.4512.2012.4111.34
Upgrade
Tangible Book Value
1,2351,1961,1691,1841,082
Upgrade
Tangible Book Value Per Share
12.8312.4512.2012.4111.34
Upgrade
Land
210.22210.22210.22210.22210.22
Upgrade
Buildings
290.85288.9286.98258.26263.3
Upgrade
Machinery
981.77965.22950.97915.59858.72
Upgrade
Construction In Progress
14.986.076.9642.4356.22
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.